Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol effects on the human pain, autonomic, and enteric nervous systems
2017-000141-52Phase 4Completed
- Sponsor
- Asbjørn Mohr Drewes
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tapentadol and oxycodone in chronic pain (3 arms), sponsored by Asbjørn Mohr Drewes. Primary endpoints: Change in pain sensitivity to electrical, mechanical, and thermal stimulation, Effect on autonomic nervous system function and 1 more. Started Feb 2017; status: completed.
02
Drugs
tapentadoloxycodone
03
Conditions
chronic pain
Beyond the preview
Go deeper on 2017-000141-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000141-52.